Boston Scientific Corp (BSX)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 1,591,000 | 1,282,000 | 966,000 | 956,000 | 752,000 | 653,000 | 884,000 | 810,000 | 1,041,000 | 884,000 | 310,000 | -23,000 | -353,000 | -514,000 | -233,000 | 68,000 | 481,000 | 614,000 | 920,000 | 1,321,000 |
| Total stockholders’ equity | US$ in thousands | 19,282,000 | 18,886,000 | 18,226,000 | 17,850,000 | 17,573,000 | 17,640,000 | 17,251,000 | 16,735,000 | 16,623,000 | 16,461,000 | 15,942,000 | 15,720,000 | 15,327,000 | 15,564,000 | 15,616,000 | 13,804,000 | 13,877,000 | 9,698,000 | 9,424,000 | 9,232,000 |
| ROE | 8.25% | 6.79% | 5.30% | 5.36% | 4.28% | 3.70% | 5.12% | 4.84% | 6.26% | 5.37% | 1.94% | -0.15% | -2.30% | -3.30% | -1.49% | 0.49% | 3.47% | 6.33% | 9.76% | 14.31% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,591,000K ÷ $19,282,000K
= 8.25%
The return on equity (ROE) for Boston Scientific Corp. has shown a steady increase over the past eight quarters, indicating improved profitability and efficiency in utilizing shareholders' equity.
In Q4 2023, the ROE reached 8.14%, the highest in the time period analyzed, reflecting a positive trend in the company's ability to generate profit from the shareholders' investment. This suggests that Boston Scientific Corp. is effectively utilizing its equity to generate returns for its investors.
The consistent growth in ROE from Q1 2022 to Q4 2023 indicates that the company has been successful in increasing its profitability and managing its assets efficiently. The gradual improvement in ROE demonstrates a positive trajectory for the company in terms of generating value for its shareholders.
Overall, the increasing trend in ROE for Boston Scientific Corp. reflects positively on the company's financial performance and suggests that it is effectively leveraging its equity to generate returns for its investors.
Peer comparison
Dec 31, 2023
See also:
Boston Scientific Corp Return on Equity (ROE) (Quarterly Data)